USA Financial Formulas’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$69.5K Buy
+931
New +$68.5K 0.01% 208
2026
Q2
– Sell
-533
Closed -$25.7K – 480
2026
Q1
$25.7K Sell
533
-124
-19% -$5.49K ﹤0.01% 241
2025
Q4
$27.1K Sell
657
-159
-19% -$6.38K ﹤0.01% 250
2025
Q3
$31.7K Buy
+816
New +$26.5K 0.01% 234

Other funds holding KNSA

USA Financial Formulas's KNSA Position: Q3 2026 in Review

USA Financial Formulas opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q3 2026: 931 shares worth $69.5K. The stake represents 0.01% of the portfolio and ranks #208 among its holdings. This is a return to the name: USA Financial Formulas previously reported a position in KNSA as recently as Q1 2026.

USA Financial Formulas first reported a position in KNSA in Q3 2025 and has held it in 4 quarters since. 305 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • USA Financial Formulas held 931 shares of Kiniksa Pharmaceuticals worth $69.5K as of Q3 2026.
  • Kiniksa Pharmaceuticals was a new USA Financial Formulas position in Q3 2026.
  • Kiniksa Pharmaceuticals made up 0.01% of USA Financial Formulas's portfolio in Q3 2026, its #208 holding.
  • USA Financial Formulas first reported a position in Kiniksa Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 305 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on USA Financial Formulas's 13F filing for Q3 2026, filed 16 Oct 2026.